Research on breast cancer was presented at the SABCS25 conference, with findings including a reduction in disease recurrence and death risk. Some treatments, such as an oral SERD from Roche, have shown promising results, with reported risk reductions. Various other developments and studies were also discussed at the conference, with multiple outlets highlighting key takeaways and presentations from the event.